Biosyent Inc (TSXV:RX) Stock Price, Trades & News

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It markets and delivers a diverse range of healthcare products, including over-the-counter, behind-the-counter, and prescription options. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX Pd, Inofolic, Gelclair, Cathejell, RepaGyn, Proktis-M, and Tibella. The company derives revenue from pharmaceutical and insecticide business. Geographically, it derives maximum revenue from Canada and also has its presence internationally.

Financial Strength

8/10

Name	Current	Vs Industry
Cash-To-Debt	2.85
Equity-to-Asset	0.76
Debt-to-Equity	0.07
Debt-to-EBITDA	0.2
Interest Coverage	125.86
Piotroski F-Score	6/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	10.17	Distress Grey Safe
Beneish M-Score	-2.12	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

10/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	18.9
	3-Year EBITDA Growth Rate	21
	3-Year EPS without NRI Growth Rate	22.2
	3-Year FCF Growth Rate	28.5
	3-Year Book Growth Rate	10.1
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	17.73
	Future 3-5Y Total Revenue Growth Rate Estimate	27.01

Momentum Rank

8/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	63.03
	9-Day RSI	63.01
	14-Day RSI	62.04
	3-1 Month Momentum %	5.36
	6-1 Month Momentum %	-6.59
	12-1 Month Momentum %	21.9

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	2.07
	Quick Ratio	1.29
	Cash Ratio	0.65
	Days Inventory	193.09
	Days Sales Outstanding	34.55
	Days Payable	149.95

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	1.32
	Dividend Payout Ratio	0.24
	3-Year Dividend Growth Rate	71
	Forward Dividend Yield %	1.38
	5-Year Yield-on-Cost %	1.33
	3-Year Average Share Buyback Ratio	2.4
	Shareholder Yield %	1.95

Profitability Rank

10/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	73.37
	Operating Margin %	23.96
	Net Margin %	17.72
	EBITDA Margin %	27.76
	FCF Margin %	19.82
	OCF Margin %	20.66
	ROE %	23.52
	ROA %	18.71
	ROIC %	35.75
	3-Year ROIIC %	43.45
	ROC (Joel Greenblatt) %	196.16
	ROCE %	31.53
	Years of Profitability over Past 10-Year	10
	Moat Score	4
	Tariff Resilience Score	7

GF Value Rank

10/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	18.38
	Forward PE Ratio	17.92
	PE Ratio without NRI	17.7
	Shiller PE Ratio	29.32
	Price-to-Owner-Earnings	18.44
	PEG Ratio	1.04
	PS Ratio	3.28
	PB Ratio	3.89
	Price-to-Tangible-Book	9.26
	Price-to-Free-Cash-Flow	16.49
	Price-to-Operating-Cash-Flow	15.81
	EV-to-EBIT	12.77
	EV-to-EBITDA	11.14
	EV-to-Revenue	3.1
	EV-to-Forward-Revenue	2.38
	EV-to-FCF	15.82
	Price-to-GF-Value	0.86
	Price-to-Projected-FCF	1.44
	Price-to-DCF (Earnings Based)	1.02
	Price-to-DCF (FCF Based)	0.97
	Price-to-Median-PS-Value	0.84
	Price-to-Peter-Lynch-Fair-Value	1.05
	Price-to-Graham-Number	2.7
	Price-to-Net-Current-Asset-Value	12.8
	Earnings Yield (Greenblatt) %	7.83
	FCF Yield %	6.2
	Forward Rate of Return (Yacktman) %	20.12

Financials (Next Earnings Date:2026-11-20 Est.)

Annual Quarterly TTM

TSXV:RX's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Biosyent Inc Executives

Details

GF Value™: C$18.26

TSXV:RX

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 1 Severe warning sign with RX. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil C$)	55.675
	EPS (TTM) (C$)	0.857
	Beta	0.9981
	3-Year Sharpe Ratio	1
	3-Year Sortino Ratio	2.34
	Volatility %	31.65
	14-Day RSI	62.04
	14-Day ATR (C$)	0.300002
	20-Day SMA (C$)	15.1795
	12-1 Month Momentum %	21.9
	52-Week Range (C$)	10.65 - 16
	Shares Outstanding (Mil)	11.31

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	6
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Biosyent Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Biosyent Inc Stock Events

Financials Calendars

Event	Date	Price (C$)
Third quarter earnings results for 2026	2026-11-20	In 83 days
Third quarter earnings conference call for 2026	2026-11-20	In 83 days
CAD 0.055000 Cash Dividend	2026-08-31	In 2 days
Second quarter earnings conference call for 2026	2026-08-20	14.75 (-0.27%)
Second quarter earnings results for 2026	2026-08-20	14.75 (-0.27%)
CAD 0.055000 Cash Dividend	2026-05-29	14.00 (+0.07%)
General meeting for 2026	2026-05-14 09:00	14.55 (-0.68%)
First quarter earnings conference call for 2026	2026-05-14	14.55 (-0.68%)
First quarter earnings results for 2026	2026-05-14	14.55 (-0.68%)
Annual report for 2025	2026-03-19	15.31 (+2.61%)

Show

Entries

Biosyent Inc Frequently Asked Questions

What is Biosyent Inc(TSXV:RX)'s stock price today?

The current price of TSXV:RX is C$15.75. The 52 week high of TSXV:RX is C$16.00 and 52 week low is C$10.65.

When is next earnings date of Biosyent Inc(TSXV:RX)?

The next earnings date of Biosyent Inc(TSXV:RX) is 2026-11-20 Est..

Does Biosyent Inc(TSXV:RX) pay dividends? If so, how much?

The Dividend Yield % of Biosyent Inc(TSXV:RX) is 1.32% (As of Today), Highest Dividend Payout Ratio of Biosyent Inc(TSXV:RX) was 0.3. The lowest was 0.09. And the median was 0.27. The Forward Dividend Yield % of Biosyent Inc(TSXV:RX) is 1.38%. For more information regarding to dividend, please check our Dividend Page.

Press Release

	Subject	Date
	BioSyent to Present at The LD 500 Virtual Conference	2020-08-24

10/Page

Articles on Biosyent Inc

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.